Elixxer Ltd. is a Canadian investment company focused on the global legal cannabis market, specializing in the cultivation, production, and sale of cannabis and cannabis-derived products. Headquartered in Montreal, it primarily invests in health, wellness, and beauty sectors related to cannabis, including pharmaceuticals and nutraceuticals. The company targets growth-stage enterprises in jurisdictions where cannabis is legally cultivated and produced, with a presence in Canada, Europe, and Jamaica. Established in 2004, Elixxer plays a role as a cannabis-focused investor, linking capital with the evolving cannabis industry across multiple international markets.